957793-36-1 Usage
General Description
Trans-3-aminocyclobutanecarboxylic acid ethyl ester hydrochloride is a chemical compound that consists of a cyclobutanecarboxylic acid core with an ethyl ester and a hydrochloride group attached. It is an important intermediate in the synthesis of various pharmaceuticals and fine chemicals. As a hydrochloride salt, it is a stable and solid form of the compound that is easily soluble in water. This chemical is commonly used in pharmaceutical research and development, as well as in the production of other organic compounds. It is important to handle and store trans-3-aminocyclobutanecarboxylic acid ethyl ester hydrochloride with proper safety measures, as it is a potentially hazardous material.
Check Digit Verification of cas no
The CAS Registry Mumber 957793-36-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,7,9 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 957793-36:
(8*9)+(7*5)+(6*7)+(5*7)+(4*9)+(3*3)+(2*3)+(1*6)=241
241 % 10 = 1
So 957793-36-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO2.ClH/c1-2-10-7(9)5-3-6(8)4-5;/h5-6H,2-4,8H2,1H3;1H/t5-,6-;
957793-36-1Relevant articles and documents
ISOXAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF PULMONARY DISEASES AND DISORDERS
-
Paragraph 0192, (2017/03/21)
The present disclosure features disclosed method of treating disorders such as COPD, bronchitis and/or asthma using disclosed compounds, optionally together with one or more additional active agents. Contemplated methods include administrating orally or by inhalation to a patient one or more disclosed compounds.
Novel indazoles for the treatment and prophylaxis of respiratory syncytial virus infection
-
Paragraph 0597-0598, (2016/08/17)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5, R7, A1, A2 and A3 are as described herein, compositions including the compounds and methods of using the compounds.
CYCLOBUTYL CARBOXYLIC ACID DERIVATIVES
-
Page/Page column 47, (2009/06/27)
The invention relates to compounds of formula (I) and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimm
